TG Therapeutics (TGTX) Earnings Date & Reports

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TGTX is expected to report earnings to rise 9.53% to 16 cents per share on May 06

TG Therapeutics TGTX Stock Earnings Reports

Q1'25

Est.

$0.16

Q4'24

Beat

by $0.07

Q3'24

Est.

$0.02

Q2'24

Beat

by $0.09

Q1'24

Missed

by $0.03

The last earnings report on March 03 showed earnings per share of 15 cents, beating the estimate of 7 cents. With 983.57K shares outstanding, the current market capitalization sits at 5.86B.

View a ticker or compare two or three

Compare

TGTX